Results 151 to 160 of about 2,886,007 (195)

(Trans)buccal drug delivery

open access: yes, 2020
Sandri, Giuseppina   +5 more
openaire   +3 more sources

Current status and the future of buccal drug delivery systems

open access: yesExpert Opinion on Drug Delivery, 2008
Background : The delivery of drugs through the buccal mucosa has received a great deal of attention over the last two decades, and yet there are not many buccal delivery products available on the market.
sevda Senel, Michael J Rathbone
exaly   +2 more sources

Current Status of Mucoadhesive Gel Systems for Buccal Drug Delivery

open access: yesCurrent Pharmaceutical Design, 2021
Background: Buccal drug delivery is a fascinating research field. Gel-based formulations present potent characteristics as buccal systems since they have great physicochemical properties.
Ayse Pinar Yağcılar   +2 more
exaly   +2 more sources

Advances in Buccal Drug Delivery

Critical Reviews in Therapeutic Drug Carrier Systems, 2005
The buccal route offers an attractive alternative for systemic drug delivery of drugs because of better patient compliance, ease of dosage form removal in emergencies, robustness, and good accessibility. Use of buccal mucosa for drug absorption was first attempted by Sobrero in 1847, and since then much research was done to deliver drugs through this ...
Raj, Birudaraj   +3 more
openaire   +2 more sources

Buccal Drug Delivery Systems

Drug Development and Industrial Pharmacy, 1995
AbstractBuccal administration offers certain unique advantages for the drugs which cannot be easily or efficiently administered by oral or intravenous route. However, transbucccal delivery receiived relatively little attention and few well-controlled studies of buccal mucosa permeability have been conducted.
N. Chidambaram, A. K. Srivatsava
openaire   +1 more source

Buccal Drug Delivery

2011
The buccal cavity can be most useful for delivery of drugs for systemic effects. Advantages can include rapid onset of action, avoidance of presystemic elimination, which may include gastrointestinal degradation, first-pass clearance by the liver, or transformation by intestinal mucosal enzymes, e.g., CYP450.
Michael A. Repka   +2 more
openaire   +1 more source

Buccal drug delivery

Expert Opinion on Drug Delivery, 2005
Buccal formulations have been developed to allow prolonged localised therapy and enhanced systemic delivery. The buccal mucosa, however, while avoiding first-pass effects, is a formidable barrier to drug absorption, especially for biopharmaceutical products (proteins and oligonucleotides) arising from the recent advances in genomics and proteomics. The
openaire   +2 more sources

Buccal delivery for peptide drugs

Journal of Controlled Release, 1992
Abstract The non-parenteral delivery of peptides via mucosal routes is essential for the enlargement of the therapeutic benefit of various oligopeptides. Among the routes under discussion the buccal mucosa was found to allow permeation of therapeutically relevant doses, e.g.
Hans P. Merkle, Gregor Wolany
openaire   +1 more source

Evaluation of polymeric films for buccal drug delivery

Die Pharmazie, 2009
The objective of this study was to evaluate the suitability of the bioadhesive polymers Carbopol 981 NF, Carbopol 1382 and sodium alginate as possible carriers for films for buccal drug delivery. Films were prepared by casting and solvent evaporation method, using propylene glycol as plasticizer and hydoxypropylmethyl cellulose to modify the properties
S, Skulason   +3 more
openaire   +2 more sources

Buccal Drug Delivery System-A Novel Drug Delivery System

Research Journal of Science and Technology, 2016
Buccal delivery is defined as drug administration through the mucosal membranes lining the cheeks (buccal mucosa). The main impediment to the use of many hydrophilic macromolecular drugs as potential therapeutic agents is their inadequate and erratic oral absorption.
Debjit Bhowmik   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy